GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Deepverge PLC (LSE:DVRG) » Definitions » EBITDA Margin %

Deepverge (LSE:DVRG) EBITDA Margin % : -5.97% (As of Jun. 2022)


View and export this data going back to 2017. Start your Free Trial

What is Deepverge EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Deepverge's EBITDA for the six months ended in Jun. 2022 was £-0.38 Mil. Deepverge's Revenue for the six months ended in Jun. 2022 was £6.44 Mil. Therefore, Deepverge's EBITDA margin for the quarter that ended in Jun. 2022 was -5.97%.


Deepverge EBITDA Margin % Historical Data

The historical data trend for Deepverge's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deepverge EBITDA Margin % Chart

Deepverge Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only -1,801.08 -500.73 -222.11 -35.76 -0.42

Deepverge Semi-Annual Data
Dec13 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -54.98 -30.24 -22.84 11.94 -5.97

Competitive Comparison of Deepverge's EBITDA Margin %

For the Health Information Services subindustry, Deepverge's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Deepverge's EBITDA Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Deepverge's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Deepverge's EBITDA Margin % falls into.



Deepverge EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Deepverge's EBITDA Margin % for the fiscal year that ended in Dec. 2021 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=-0.039/9.297
=-0.42 %

Deepverge's EBITDA Margin % for the quarter that ended in Jun. 2022 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2022 )/Revenue (Q: Jun. 2022 )
=-0.384/6.436
=-5.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Deepverge  (LSE:DVRG) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Deepverge EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Deepverge's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Deepverge (LSE:DVRG) Business Description

Traded in Other Exchanges
N/A
Address
12 St. James’s Terrace, Malahide, Dublin, IRL, K36 N996
Deepverge PLC is a scientific research company focused on the production and analysis of bacteria, viruses, and toxins utilizing artificial intelligent data analytics in regulatory technology, from scientifically proving the impact of skincare product claims on skin microbiome for global cosmetic company clients to remotely detecting water contamination in real-time. The company segments include Life Science, Data AI and Monitoring out of which it generates maximum revenue from Monitoring.

Deepverge (LSE:DVRG) Headlines

No Headlines